Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Depomed Inc (DEPO) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 1,004,986
  • Shares Outstanding, K 61,580
  • Annual Sales, $ 342,740 K
  • Annual Income, $ -75,740 K
  • 36-Month Beta 1.33
  • Price/Sales 2.27
  • Price/Cash Flow 57.20
  • Price/Book 4.13

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.64 +4.35%
on 02/21/17
18.40 -11.30%
on 02/03/17
-1.65 (-9.18%)
since 01/24/17
3-Month
15.64 +4.35%
on 02/21/17
21.38 -23.67%
on 01/04/17
-4.00 (-19.69%)
since 11/23/16
52-Week
12.25 +33.22%
on 03/24/16
27.02 -39.60%
on 09/30/16
-0.79 (-4.62%)
since 02/24/16

Most Recent Stories

More News
Could 2017 Prove to be a Bull Market for Biotechs? Today's Reports on Depomed and Amicus Therapeutics

NEW YORK, NY / ACCESSWIRE / February 23, 2017 / The Biotech Industry has posted some impressive gains since election result and the rally has continued for the larger part of this year. Both the iShares...

FOLD : 5.96 (-1.49%)
XBI : 67.24 (+0.15%)
DEPO : 16.32 (-3.03%)
Depomed to Report Fourth Quarter Fiscal Year 2016 Financial Results on Tuesday, February 21, 2017

Depomed, Inc. (NASDAQ:DEPO) today announced that it will release fourth quarter fiscal year 2016 financial results after the close of market, Tuesday, February 21, 2017. The Company will host a conference...

DEPO : 16.32 (-3.03%)
First Week of September 15th Options Trading For Depomed (DEPO)

Investors in Depomed Inc saw new options become available this week, for the September 15th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time...

DEPO : 16.32 (-3.03%)
McKesson and Morgan Stanley climb; Southwestern Energy drops

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:

FCAU : 10.79 (-2.35%)
EXC : 37.18 (+3.34%)
MCK : 150.85 (+1.26%)
EXCU : 49.62 (+1.02%)
SWN : 7.35 (-11.98%)
FB : 135.44 (+0.06%)
XRX : 7.54 (+0.13%)
DEPO : 16.32 (-3.03%)
Research Reports Coverage on Drug Makers Stocks -- Depomed, DURECT, United Therapeutics, and Amphastar Pharma

The Drug Manufacturers industry is focused on the research, distribution, and marketing of pharmaceutical drug products. Companies in this space typically have dividend yields that are higher than the...

DRRX : 0.98 (+1.03%)
AMPH : 15.19 (+2.57%)
UTHR : 146.71 (-0.50%)
DEPO : 16.32 (-3.03%)
Depomed to Present at the Annual Piper Jaffray Healthcare Conference

Depomed, Inc. (NASDAQ:DEPO) today announced that it will participate in a fireside chat at the 28th Annual Piper Jaffray Healthcare Conference scheduled for 2:00 pm ET (11:00 am PT) on Tuesday, November...

DEPO : 16.32 (-3.03%)
Blog Coverage Cumberland Pharma Bags Exclusive Rights for Europe Based Nordic Group Injectable Methotrexate Product Line for the US Market

Upcoming AWS Coverage on Depomed Post-Earnings Results

CPIX : 5.66 (-0.88%)
DEPO : 16.32 (-3.03%)
Upgrade Alert for Depomed (DEPO)

Depomed (NASDAQ:DEPO) was upgraded from Neutral to Buy at Mizuho today. The stock closed yesterday at $19.76 on volume of 4.7 million shares, above average daily volume of 2.2 million. DepoMed, Inc....

DEPO : 16.32 (-3.03%)
Downgrade Alert for Depomed (DEPO)

Depomed (NASDAQ:DEPO) was downgraded from Buy to Hold at Cantor today. The stock closed yesterday at $19.01 on volume of 10.9 million shares, above average daily volume of 2.2 million. Depomed (NASDAQ:DEPO)...

DEPO : 16.32 (-3.03%)
Hertz and CVS plunge; SeaWorld, Priceline gain

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:

VRX.TO : 21.20 (-2.48%)
CVS : 81.48 (+0.77%)
W : 39.30 (+1.87%)
VRX : 16.18 (-2.41%)
HTZ : 19.97 (-0.60%)
DEPO : 16.32 (-3.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Depomed, Inc. is a specialty pharmaceutical company utilizing its innovative AcuForm drug delivery technology to develop novel oral products and improved, extended release formulations of existing oral drugs. AcuForm-based products are designed to provide once- daily administration and reduced side effects,...

See More

Support & Resistance

2nd Resistance Point 16.96
1st Resistance Point 16.64
Last Price 16.32
1st Support Level 16.09
2nd Support Level 15.86

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.